XML 31 R21.htm IDEA: XBRL DOCUMENT
v3.24.3

Accrued Expenses (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Accrued Liabilities, Current [Abstract] |
Schedule of Accrued Expenses | Accrued expenses consisted of the following (in thousands):
|  | September 30, 2024 |  |  | December 31, 2023 |
Accrued clinical and other research and development |  | $ | 13,649 |  |  | $ | 6,769 |
Accrued manufacturing |  |  | 13,425 |  |  |  | 6,830 |
Accrued employee compensation and benefits |  |  | 6,827 |  |  |  | 7,326 |
Accrued other |  |  | 1,297 |  |  |  | 1,624 |
|  | $ | 35,198 |  |  | $ | 22,549 |

X
- References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesCurrentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration